FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmacology and represents oncologic sensibiliser, which contains compound, selected from glucosamine, glucosamine derivative, represented by formula 2.
EFFECT: reduction of chemoresistance of cancer cells.
4 cl, 4 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS AND METHODS FOR CONTROLLING CARDIOTOXICITY CAUSED BY CHEMOTHERAPY | 2017 |
|
RU2743433C2 |
| BIFUNCTIONAL COMPOSITIONS FOR CANCER TREATMENT | 2019 |
|
RU2764175C1 |
| TAXANES COVALENTLY BONDED WITH HYALURONIC ACID OR HYALURONIC ACID DERIVATIVES | 2003 |
|
RU2384593C2 |
| ANTICANCER COMPOSITION | 2019 |
|
RU2789245C2 |
| SODIUM COBALT POLYGALACTURONATE WITH ANTITUMOR ACTIVITY | 2023 |
|
RU2794885C1 |
| COMBINED COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING BENZOPHENONE-THIAZOLE DERIVATIVES AS VDA AND TOPOISOMERASE INHIBITOR | 2017 |
|
RU2724341C1 |
| COMBINATIONS OF ANTIFOLATE AGENT IN CANCER TREATMENT | 2007 |
|
RU2423114C2 |
| CYCLIC C-TERMINAL PEPTIDE OF ACETYLCHOLINESTERASE IN TREATING OR PREVENTING CANCER OR METASTASIS | 2015 |
|
RU2711161C2 |
| CANCER THERAPY BY COMBINATION OF TAXANES AND 13-DEOXYANTRACYCLINES | 2007 |
|
RU2421224C2 |
| HISTONE DEACETYLASE INHIBITOR-CONTAINING PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2322971C2 |
